| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Dr. Sulaiman Al Habib Medical Services Group has decided on 2nd May 2026 Corresponding to 15th Dhu Al-Qadah 1447H to distribute cash dividends to the shareholders for the First quarter of 2026. |
| Date of the board’s decision | 2026-05-02 Corresponding to 1447-11-15 |
| The Total amount distributed | SAR 353.50 million |
| Number of Shares Eligible for Dividends | 350 million shares |
| Dividend per share | SAR 1.01 per share |
| Percentage of Dividend to the Share Par Value (%) | 10.1 |
| Eligibility date | 2026-05-07 Corresponding to 1447-11-20 |
| Distribution Date | 2026-05-21 Corresponding to 1447-12-04 |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | na |
| Additional Information | The Company would like to inform non-resident investors that distribution of cash dividends are subject to a 5% withholding tax, as per the provisions of Article (68) of the Income Tax Law and Article (63) of its Executive Regulations. |
Non-resident investors who are eligible for tax exemptions on dividends issued by the Zakat, Tax, and Customs Authority are kindly requested to contact the Investor Relations Department and provide the necessary supporting documents to confirm their exemption.
Additionally, the Company urges all shareholders to ensure that their personal and banking information is up to date and that their bank account numbers are linked to their investment portfolios. This will help facilitate the timely deposit of future dividend payments.
For any inquiries or further assistance, please contact the Investor Relations Department using the following contact Details:
Phone: + 966 (11) 5259999 Ext: 4919
Email: investor.relations@drsulaimanalhabib.com
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.